Target and Pathway |
Top |
Target(s) |
Erbb3 tyrosine kinase receptor (Erbb-3) |
Target Info
|
Modulator |
[3] |
Insulin-like growth factor I receptor (IGF1R) |
Target Info
|
Modulator |
[3] |
Serine/threonine-protein kinase mTOR (mTOR) |
Target Info
|
Inhibitor |
[1] |
KEGG Pathway
|
Ras signaling pathway
|
Rap1 signaling pathway
|
HIF-1 signaling pathway
|
FoxO signaling pathway
|
Oocyte meiosis
|
Endocytosis
|
PI3K-Akt signaling pathway
|
AMPK signaling pathway
|
Focal adhesion
|
Adherens junction
|
Signaling pathways regulating pluripotency of stem cells
|
Long-term depression
|
Ovarian steroidogenesis
|
Progesterone-mediated oocyte maturation
|
Pathways in cancer
|
Transcriptional misregulation in cancer
|
Proteoglycans in cancer
|
Glioma
|
Prostate cancer
|
Melanoma
|
ErbB signaling pathway
|
Calcium signaling pathway
|
MicroRNAs in cancer
|
mTOR signaling pathway
|
Insulin signaling pathway
|
Thyroid hormone signaling pathway
|
Adipocytokine signaling pathway
|
Type II diabetes mellitus
|
Acute myeloid leukemia
|
Central carbon metabolism in cancer
|
Choline metabolism in cancer
|
NetPath Pathway
|
TNFalpha Signaling Pathway
|
Panther Pathway
|
Insulin/IGF pathway-mitogen activated protein kinase kinase/MAP kinase cascade
|
Insulin/IGF pathway-protein kinase B signaling cascade
|
Cadherin signaling pathway
|
EGF receptor signaling pathway
|
Hypoxia response via HIF activation
|
Interleukin signaling pathway
|
Pathwhiz Pathway
|
Leucine Stimulation on Insulin Signaling
|
Pathway Interaction Database
|
Plasma membrane estrogen receptor signaling
|
SHP2 signaling
|
IGF1 pathway
|
Posttranslational regulation of adherens junction stability and dissassembly
|
Integrins in angiogenesis
|
Stabilization and expansion of the E-cadherin adherens junction
|
ErbB2/ErbB3 signaling events
|
ErbB receptor signaling network
|
a6b1 and a6b4 Integrin signaling
|
IL4-mediated signaling events
|
Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)
|
IL12-mediated signaling events
|
CDC42 signaling events
|
LKB1 signaling events
|
Regulation of Telomerase
|
mTOR signaling pathway
|
CXCR4-mediated signaling events
|
EGFR-dependent Endothelin signaling events
|
IL2 signaling events mediated by PI3K
|
IFN-gamma pathway
|
ErbB1 downstream signaling
|
CXCR3-mediated signaling events
|
Class I PI3K signaling events mediated by Akt
|
Reactome
|
IRS-related events triggered by IGF1R
|
SHC-related events triggered by IGF1R
|
PIP3 activates AKT signaling
|
Macroautophagy
|
mTORC1-mediated signalling
|
HSF1-dependent transactivation
|
CD28 dependent PI3K/Akt signaling
|
VEGFR2 mediated vascular permeability
|
TP53 Regulates Metabolic Genes
|
Constitutive Signaling by AKT1 E17K in Cancer
|
WikiPathways
|
Senescence and Autophagy in Cancer
|
Insulin Signaling
|
Endochondral Ossification
|
Focal Adhesion
|
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
|
Apoptosis
|
Signaling Pathways in Glioblastoma
|
TSH signaling pathway
|
MicroRNAs in cardiomyocyte hypertrophy
|
ErbB Signaling Pathway
|
Apoptosis-related network due to altered Notch3 in ovarian cancer
|
miR-targeted genes in muscle cell - TarBase
|
Heart Development
|
Interferon type I signaling pathways
|
EGF/EGFR Signaling Pathway
|
Wnt Signaling Pathway Netpath
|
Extracellular vesicle-mediated signaling in recipient cells
|
Cardiac Hypertrophic Response
|
PIP3 activates AKT signaling
|
Polycystic Kidney Disease Pathway
|
Alpha 6 Beta 4 signaling pathway
|
BDNF signaling pathway
|
Oncostatin M Signaling Pathway
|
Prostate Cancer
|
TSLP Signaling Pathway
|
FSH signaling pathway
|
Leptin signaling pathway
|
RANKL/RANK Signaling Pathway
|
SREBF and miR33 in cholesterol and lipid homeostasis
|
Integrated Breast Cancer Pathway
|
SREBP signalling
|
Signaling by Insulin receptor
|
Costimulation by the CD28 family
|
Type II diabetes mellitus
|
TOR Signaling
|
AMPK Signaling
|